Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Positive proof of concept results for SUDCA

Jan. 5, 2004

CTX granted for phase IIa trial of ATL-104 for mucositis

Jan. 5, 2004

First patient enrolled in trial of dendritic cell vaccine for melanoma

Jan. 5, 2004

Tributyrin induces apoptosis of leukemia cell lines

Dec. 30, 2003

Potential clinical benefits of CAI in ovarian cancer

Dec. 30, 2003

European orphan drug designation for gimatecan for glioma

Dec. 30, 2003

Enrollment completed in phase IIa study of PCK-3145

Dec. 30, 2003

GTI-2501 enters phase II

Dec. 30, 2003

CPMP rejects PharmaMar appeal regarding Yondelis

Dec. 30, 2003

Novacea stops enrollment in DN-101 trial for MDS

Dec. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...